Overview
Allan Rubenstein is a Neurologist in New York, New York. Dr. Rubenstein is rated as an Advanced provider by MediFind in the treatment of Neurofibromatosis. His top areas of expertise are Neurofibromatosis and Neurofibromatosis Type 1 (NF1).
His clinical research consists of co-authoring 4 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 3 articles in the study of Neurofibromatosis.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- HMO
- POS
- PPO
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Memorial Sloan Kettering Cancer Center
Anna Piotrowski is a Neurologist in New York, New York. Dr. Piotrowski has been practicing medicine for over 16 years and is rated as a Distinguished provider by MediFind in the treatment of Neurofibromatosis. Her top areas of expertise are Astrocytoma, Glioma, Posterior Fossa Tumor, and Brain Tumor. Dr. Piotrowski is currently accepting new patients.
Trustees Of Columbia University In The City Of New York
Gurcharanjeet Kaur is a Pediatric Neurologist and a Neurologist in New York, New York. Dr. Kaur has been practicing medicine for over 16 years and is rated as an Advanced provider by MediFind in the treatment of Neurofibromatosis. Her top areas of expertise are Neurofibromatosis Type 1 (NF1), Neurofibromatosis, Seizures, and Zika Virus Disease.
Memorial Neurology Group
Andrew Lin is a Neurologist in New York, New York. Dr. Lin is rated as a Distinguished provider by MediFind in the treatment of Neurofibromatosis. His top areas of expertise are Brain Tumor, Glioma, Astrocytoma, and Glioblastoma.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- NeurofibromatosisDr. Rubenstein isAdvanced. Learn about Neurofibromatosis.
- Neurofibromatosis Type 1 (NF1)Dr. Rubenstein isAdvanced. Learn about Neurofibromatosis Type 1 (NF1).